Suppr超能文献

[改良BFM-90方案对儿童及青少年伴感染的淋巴细胞淋巴瘤的预防及治疗]

[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].

作者信息

Zhen Zi-Jun, Xia Yi, Ling Jia-Yu, Tong Gang-Ling, Lin Lin, Cai Yue, Sun Xiao-Fei

机构信息

State Key Laboratory of Oncology in South China, Guangzhou, Guargdong, 510060, People's Republic of China.

出版信息

Ai Zheng. 2009 Jul;28(7):718-24. doi: 10.5732/cjc.008.10673.

Abstract

BACKGROUND AND OBJECTIVE

Modified BFM-90 regimen has significantly improved the outcome of lymphoblastic lymphoma in children and adolescents. Infection is the main side effect of this regimen, which may affect the treatment efficacy and prognosis without proper intervention. This study was to summarize the characteristics of the modified BFM-90 regimen related infection, and explore effective approaches to treat the infection.

METHODS

The infection rate, site, pathogen were reviewed for the infections of 104 children and adolescents suffering from lymphoblastic lymphoma at different phases of the modified BFM-90 regimen. The relationship between chemotherapy, bone marrow suppression and infection was analyzed. The value of procalcitonin (PCT) in identifying the infection type and the outcome of anti-infection treatment was evaluated.

RESULTS

The infection rates in reduction phases Ia, Ib and re-reduction phases IIa, IIb were 52.5%, 60.7% and 48.6%, 28.2%, respectively. The infection rate in consolidation chemotherapy for patients with low to intermediate risk and high risk were 17.2% and 100%, respectively. In total 302 infections occurred. One hundred and sixty-seven cases (55.3%) had documented infection sites, most of which happened to the respiratory tract. Ninety-five cases (31.5%) had documented pathogens, most of which were Gram-negative bacteria. Infections of 262 cases (86.8%) were secondary to bone marrow suppression. The sensitivity and specificity of PCT in diagnosing sepsis were 83.3% and 70.2%, but it failed to identify the infection type. After the anti-infection treatment, 296 cases were cured, four cases gave up further treatment due to financial difficulties, two cases died of sepsis.

CONCLUSIONS

Infections caused by modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents are closely correlated to bone marrow suppression. The positive diagnosis rate of the pathogen is too low to identify most of the infection type. The treatment still mainly depends on experience.

摘要

背景与目的

改良BFM-90方案显著改善了儿童和青少年淋巴细胞性淋巴瘤的治疗效果。感染是该方案的主要副作用,若不进行适当干预,可能会影响治疗效果和预后。本研究旨在总结改良BFM-90方案相关感染的特征,并探索有效的感染治疗方法。

方法

回顾了104例接受改良BFM-90方案不同阶段治疗的儿童和青少年淋巴细胞性淋巴瘤患者的感染率、感染部位及病原体。分析了化疗、骨髓抑制与感染之间的关系。评估了降钙素原(PCT)在识别感染类型及抗感染治疗结局方面的价值。

结果

Ia、Ib期减量阶段及IIa、IIb期再减量阶段的感染率分别为52.5%、60.7%及48.6%、28.2%。低中危和高危患者巩固化疗阶段的感染率分别为17.2%和100%。共发生302次感染。167例(55.3%)有明确记录的感染部位,其中大部分发生在呼吸道。95例(31.5%)有明确记录的病原体,其中大部分为革兰阴性菌。262例(86.8%)感染继发于骨髓抑制。PCT诊断脓毒症的敏感度和特异度分别为83.3%和70.2%,但无法识别感染类型。抗感染治疗后,296例治愈,4例因经济困难放弃进一步治疗,2例死于脓毒症。

结论

改良BFM-90方案所致儿童和青少年淋巴细胞性淋巴瘤感染与骨髓抑制密切相关。病原体阳性诊断率过低,无法识别大多数感染类型。治疗仍主要依靠经验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验